133 related articles for article (PubMed ID: 3653852)
1. Elevation of chemotactic factor inactivator in alcoholic liver disease.
Robbins RA; Zetterman RK; Kendall TJ; Gossman GL; Monsour HP; Rennard SI
Hepatology; 1987; 7(5):872-7. PubMed ID: 3653852
[TBL] [Abstract][Full Text] [Related]
2. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
[TBL] [Abstract][Full Text] [Related]
3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
[TBL] [Abstract][Full Text] [Related]
5. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
Robbins RA; Hamel FG
J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
[TBL] [Abstract][Full Text] [Related]
6. Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome.
Robbins R; Maunder R; Gossman G; Kendall T; Hudson L; Rennard S
Am Rev Respir Dis; 1990 Jun; 141(6):1463-8. PubMed ID: 2350087
[TBL] [Abstract][Full Text] [Related]
7. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
9. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
Rhodes JM; Potter BJ; Brown DJ; Jewell DP
Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
11. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the regulation of complement-derived chemotactic factors in blunt trauma.
Maderazo EG; Moore M; Woronick CL
J Infect Dis; 1988 Feb; 157(2):364-7. PubMed ID: 3335811
[No Abstract] [Full Text] [Related]
13. Elevation of serum chemotactic factor inactivator activity in rabbits induced by inflammation and chemotactic factor.
Hupp JR; Despins AW; McCormick JR; Armstrong G; Kreutzer DL
Am J Pathol; 1982 Dec; 109(3):277-82. PubMed ID: 7180941
[TBL] [Abstract][Full Text] [Related]
14. Role of chemotactic factor inactivation in neutrophil chemotaxis.
Tannous R; Cavender-Zylich N; Ginsberg BH
J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
Tonnesen MG; Smedly LA; Henson PM
J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory proteins: chemical and biological aspects.
Ward PA
Clin Biochem; 1980 Oct; 13(5):187-90. PubMed ID: 7006854
[No Abstract] [Full Text] [Related]
17. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
Hugli TE
Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
[No Abstract] [Full Text] [Related]
18. Elevation of serum chemotactic factor inactivator activity during acute inflammatory reactions in patients with hypersensitivity pneumonitis.
Kreutzer DL; McCormick JR; Thrall RS; Hupp JR; Moore VL; Fink JN
Am Rev Respir Dis; 1982 May; 125(5):612-4. PubMed ID: 7081823
[TBL] [Abstract][Full Text] [Related]
19. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
Matzner Y; Marx G; Drexler R; Eldor A
Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
